Evidence map›Paper›PMID 24860162›Full record

ArticleCancer research2014

Mechanisms promoting escape from mitotic stress-induced tumor cell death.

Rebecca Sinnott, Leah Winters, Brittany Larson, Daniela Mytsa, Patrick Taus, Kathryn M Cappell, Angelique W Whitehurst

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Trim69 is a microtubule regulator that acts as a pantropic viral inhibitor.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Article
  10. Review
  11. Computational and mathematical methods in medicine · 2022
    Article
  12. Review
  13. Article
  14. Targeting mitotic exit in solid tumors.American journal of cancer research · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Rebecca SinnottAuthors' Affiliations: Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill;
Leah WintersDepartment of Anesthesiology, University of Colorado, Aurora, Colorado; and.
Brittany LarsonWake Forest University School of Medicine, Winston-Salem, North Carolina;
Daniela MytsaAuthors' Affiliations: Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill;
Patrick TausAuthors' Affiliations: Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill;
Kathryn M CappellDepartment of Medicine, Stanford University, Stanford, California.
Angelique W WhitehurstAuthors' Affiliations: Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill; angelique.whitehurst@utsouthwestern.edu.
University of North Carolina at Chapel Hill · USStanford University · USUniversity of Colorado Denver · USWake Forest University · US

Funding

PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIST32GM007040 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NICHOLAS, ROBERT A · 1985 to 2019
$6.0M
CANCER CELL BIOLOGY TRAINING PROGRAMT32CA071341 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHANNING J. DER, Yuliya Pylayeva-Gupta · 1996 to 2026
$5.0M
Mechanistic Elaboration of Fragility in the Cancer Cell Mitotic SpindleR01CA154699 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITEHURST, ANGELIQUE WRIGHT · 2011 to 2015
$1.5M
Harnessing Functional Genomics to Reveal Cancer Specific Determinants of MitosisR00CA128926 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITEHURST, ANGELIQUE WRIGHT · 2009 to 2011
$726k
Harnessing Functional Genomics to Reveal Cancer Specific Determinants of MitosisK99CA128926 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITEHURST, ANGELIQUE WRIGHT · 2008 to 2008
$94k
NCI NIH HHS CA071341-14NCI NIH HHS CA128926NCI NIH HHS CA154699NCI NIH HHS K99 CA128926NCI NIH HHS R00 CA128926NCI NIH HHS R01 CA154699NCI NIH HHS T32 CA071341NIGMS NIH HHS T32 GM007040NIGMS NIH HHS T32GM007040-37
6 · The paper itself

Abstract

Non-small cell lung cancer (NSCLC) is notorious for its paltry responses to first-line therapeutic regimens. In contrast to acquired chemoresistance, little is known about the molecular underpinnings of the intrinsic resistance of chemo-naïve NSCLC. Here we report that intrinsic resistance to paclitaxel in NSCLC occurs at a cell-autonomous level because of the uncoupling of mitotic defects from apoptosis. To identify components that permit escape from mitotic stress-induced death, we used a genome-wide RNAi-based strategy, which combines a high-throughput toxicity screen with a live-cell imaging platform to measure mitotic fate. This strategy revealed that prolonging mitotic arrest with a small molecule inhibitor of the APC/cyclosome could sensitize otherwise paclitaxel-resistant NSCLC. We also defined novel roles for CASC1 and TRIM69 in supporting resistance to spindle poisons. CASC1, which is frequently co-amplified with KRAS in lung tumors, is essential for microtubule polymerization and satisfaction of the spindle assembly checkpoint. TRIM69, which associates with spindle poles and promotes centrosomal clustering, is essential for formation of a bipolar spindle. Notably, RNAi-mediated attenuation of CASC1 or TRIM69 was sufficient to inhibit tumor growth in vivo. On the basis of our results, we hypothesize that tumor evolution selects for a permissive mitotic checkpoint, which may promote survival despite chromosome segregation errors. Attacking this adaptation may restore the apoptotic consequences of mitotic damage to permit the therapeutic eradication of drug-resistant cancer cells.

Indexed as

MitosisStress, PhysiologicalAnimalsAntineoplastic AgentsCarcinoma, Non-Small-Cell LungCell Cycle CheckpointsCell DeathCell Line, TumorDisease Models, AnimalDrug Resistance, NeoplasmFemaleHeterograftsHumansLung NeoplasmsMiceMicrotubulesAntineoplastic AgentsPaclitaxelTRIM69 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID24860162
PMCPMC4102622
OpenAlexW1976672042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.